Embody vs Oak Longevity: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats Embody overall, scoring 7.5/10 vs 7.3/10. Oak Longevity is more affordable at $130/mo vs $299/mo. Choose Embody for users looking for the lowest entry price with round-the-cloc. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.
A side-by-side comparison of Embody and Oak Longevity covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#33 of 42Compounded tirzepatide provider offering both injectable and oral dissolvable gum formats — the only tracked platform with a non-injectable tirzepatide option. $149 first month includes medication, metabolic report, and 1:1 guidance; $299/mo for ongoing refills.
Visit EmbodyOak Longevity
#23 of 42Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.
Visit Oak Longevity| Feature | Embody | Oak Longevity |
|---|---|---|
| Our Score | 7.3/10 | 7.5/10 |
| Starting Price | $299/mo | $130/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users looking for the lowest entry price with round-the-clock specialist support | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) |
| Ranking | #33 | #23 |
Pros & Cons Compared
Embody
Pros
- +$149 first month is one of the lowest entry prices in the GLP-1 market — includes medication, metabolic report, and 1:1 guidance
- +Oral tirzepatide gum format available — one of the few platforms offering a non-injectable tirzepatide option for needle-phobic patients
- +24/7 specialist support included at no extra cost for questions about dosing, side effects, and progress
- +Personalized metabolic report helps you understand your body's baseline before starting treatment
Cons
- −Monthly refill price jumps to $299/mo after the first month — nearly double what competitors like Mochi ($99/mo + membership) or TrimRx ($179/mo) charge
- −Compounded medications only — no brand-name Wegovy or Zepbound available through the platform
- −Limited company transparency — founding date, headquarters, and pharmacy partners are not publicly disclosed
Oak Longevity
Pros
- +$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) and Sesame Care ($99) are lower, but Oak undercuts most mid-tier platforms
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
- −No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
- −'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
- −'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform
Our Verdict
Oak Longevity edges out Embody with a score of 7.5/10 vs 7.3/10. If budget is your priority, Oak Longevity starts at $130/mo compared to Embody's $299/mo. Oak Longevity offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).